DRH Investments Inc. Boosts Stock Holdings in Chemed Corporation $CHE

DRH Investments Inc. increased its holdings in Chemed Corporation (NYSE:CHE) by 4.3% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 15,482 shares of the company’s stock after buying an additional 635 shares during the period. Chemed comprises approximately 7.8% of DRH Investments Inc.’s holdings, making the stock its 10th biggest position. DRH Investments Inc. owned 0.11% of Chemed worth $7,539,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of CHE. Norges Bank acquired a new position in Chemed in the second quarter valued at approximately $89,388,000. Acadian Asset Management LLC lifted its holdings in shares of Chemed by 69.3% in the 2nd quarter. Acadian Asset Management LLC now owns 250,722 shares of the company’s stock worth $122,056,000 after purchasing an additional 102,597 shares during the last quarter. Fuller & Thaler Asset Management Inc. boosted its position in Chemed by 249.3% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 130,037 shares of the company’s stock valued at $80,015,000 after purchasing an additional 92,813 shares during the period. Woodline Partners LP grew its stake in Chemed by 2,681.0% during the 1st quarter. Woodline Partners LP now owns 58,178 shares of the company’s stock worth $35,798,000 after buying an additional 56,086 shares during the last quarter. Finally, Nuveen LLC acquired a new stake in Chemed in the first quarter worth $30,527,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Transactions at Chemed

In related news, Director Patrick P. Grace sold 150 shares of the stock in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total transaction of $69,508.50. Following the completion of the sale, the director directly owned 3,397 shares of the company’s stock, valued at $1,574,135.83. This represents a 4.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the sale, the chief executive officer owned 94,197 shares of the company’s stock, valued at $41,215,897.35. The trade was a 2.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 5,150 shares of company stock valued at $2,328,449 over the last three months. 3.29% of the stock is owned by corporate insiders.

Chemed Price Performance

NYSE CHE opened at $438.03 on Tuesday. Chemed Corporation has a 12 month low of $408.42 and a 12 month high of $623.60. The firm has a market capitalization of $6.20 billion, a PE ratio of 23.16, a P/E/G ratio of 2.69 and a beta of 0.43. The company’s 50 day simple moving average is $440.20 and its 200 day simple moving average is $472.55.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The firm had revenue of $624.90 million during the quarter, compared to analyst estimates of $626.04 million. During the same quarter last year, the company earned $5.64 earnings per share. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Sell-side analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Monday, November 17th will be given a $0.60 dividend. The ex-dividend date is Monday, November 17th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is 12.69%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Jefferies Financial Group raised shares of Chemed from a “hold” rating to a “buy” rating and boosted their target price for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Bank of America dropped their price target on shares of Chemed from $610.00 to $595.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Royal Bank Of Canada reduced their price objective on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, November 10th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $574.25.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.